Two Sigma Investments’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
RSCM
EC
Two Sigma Investments's BPMC Position: Q2 2023 in Review
Two Sigma Investments sold out of Blueprint Medicines (BPMC) in Q2 2023, closing a stake of 12,800 shares — an estimated $576K sold.
Two Sigma Investments first reported a position in BPMC in Q3 2016 and held it in 17 quarters. The position peaked at $22.1M in Q2 2018. 222 funds tracked by Wall St. Rank hold BPMC as of Q2 2023.
- Two Sigma Investments reported no remaining Blueprint Medicines position as of Q2 2023 after selling out during the quarter.
- Two Sigma Investments sold 12,800 Blueprint Medicines shares in Q2 2023, an estimated $576K.
- Two Sigma Investments first reported a position in Blueprint Medicines in Q3 2016 and held it in 17 quarters.
- Two Sigma Investments's Blueprint Medicines position peaked at $22.1M in Q2 2018.
- 222 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2023.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.